ACE EduTremd Ltd (530093)

Asset Play

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹3.22
Market Cap₹3.02 Cr
P/E Ratio0
ROCE-7.12%
ROE-2.53%
Dividend Yield0%
Profit Growth36.84%
Debt/Equity
Sales Growth0%
52-Week Range₹4.04 — ₹4.7
SectorOther Consumer Services
Book Value₹9.14

Strengths

Concerns

AI Analysis

ACE EduTremd is priced at ₹3.22, giving a market cap of just ₹3 Cr. The first thing that catches my eye is the balance sheet: book value per share is ₹9.14, so at 0.35 times book, the market is assigning only a third of stated net worth. As a Graham-style investor, buying below book is interesting, but only if the book value is real and can generate future earnings or be liquidated. Here, the operating business is missing. The latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr. Sales growth is 0%, and with ROE at -2.53% and ROCE at -7.12%, the company is not earning a return on equity or capital; it is destroying value. P/E of 0.00 is meaningless because there are no meaningful earnings to justify a multiple. Profit growth of 36.84% sounds positive, but from a negligible base, percentage changes are noise. The Piotroski F-Score of 5/9 suggests some financial signals are okay, but not enough to call this a healthy business. The 52-week range of ₹4.04-₹4.70 is odd because the current price is below that range; either the data is stale or the stock has fallen sharply. Dividend yield is zero, so patient shareholders get no income while waiting. I cannot identify a durable moat in a company generating no sales. This looks like an asset play on stated book value, not an operating franchise. I would demand a thorough audit of every asset, especially any education-related receivables or intangibles, before trusting the ₹9.14 book value. If the assets are genuine, there may be hidden value; if not, even a ₹3 Cr market cap could be too high. I would not anchor on book multiple alone.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer